Mintz, Levin, Cohn, Ferris, Glovsky and Popeo advised Intensity Therapeutics, while Sullivan & Worcester advised the placement agents in the offering. Intensity Therapeutics, Inc. (Nasdaq: INTS)...
You must be a Standard 1 Year member to access this content.
Sullivan & Worcester advised Swvl Holdings Corp. on the offering. Swvl Holdings Corp., a UAE-based leading provider of technology-driven mobility solutions for enterprises and governments in...
You must be a Standard 1 Year member to access this content.
Lowenstein Sandler advised Sonnet BioTherapeutics, while Sullivan & Worcester advised Chardan Capital Markets on the offering. Sonnet BioTherapeutics Holdings, Inc. (Nasdaq: SONN), a clinical-stage company developing...
You must be a Standard 1 Year member to access this content.
Sullivan & Worcester advised A.G.P./Alliance Global Partners on the offering. Palladyne AI Corp. (Nasdaq: PDYN and PDYNW), a developer of artificial intelligence software for robotic platforms...
You must be a Standard 1 Year member to access this content.
Locke Lord advised Professional Diversity Network, while Sullivan & Worcester represented A.G.P./Alliance Global Partners in the offering. Professional Diversity Network, Inc. (NASDAQ: IPDN) has entered into...
You must be a Standard 1 Year member to access this content.
Dorsey & Whitney advised Shuttle Pharmaceuticals, while Sullivan & Worcester advised A.G.P./Alliance Global Partners in the offering. Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH) announced the pricing...
You must be a Standard 1 Year member to access this content.
ArentFox Schiff advised CNS Pharmaceuticals, while Sullivan & Worcester advised A.G.P./Alliance Global Partners on the offering. CNS Pharmaceuticals, Inc. closed the $3 million registered direct offering...
You must be a Standard 1 Year member to access this content.
Sullivan & Worcester represented A.G.P./Alliance Global Partners in the transaction. XORTX Therapeutics has entered into securities purchase agreements with institutional investors for the purchase and sale...
You must be a Standard 1 Year member to access this content.
Sullivan & Cromwell advised Springer Nature on the transaction, and Kirkland & Ellis advised BC Partners. Springer Nature announced its initial public offering on the Frankfurt...
You must be a Standard 1 Year member to access this content.
Herzog Fox & Neema and Sullivan advised REE Automotive Ltd. on the offering. REE Automotive Ltd. (Nasdaq: REE) executed the $45.3 million public offering of ordinary...
You must be a Standard 1 Year member to access this content.
Jones Day represented Cibus, while Sullivan & Worcester represented ROTH Capital Partners and A.G.P./Alliance Global Partners on the offering. Cibus, Inc. (Nasdaq: CBUS) announced the public...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised BioCardia, while Sullivan & Worcester advised A.G.P./Alliance Global Partners on the offering. BioCardia, Inc. (Nasdaq: BCDA) completed its $7.2 million...
You must be a Standard 1 Year member to access this content.
